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Abstract
Aim/hypothesis—Common variants in the transcription factor 7-like 2 (TCF7L2) gene have
been associated with type 2 diabetes in adults. However, it is not known whether TCF7L2
variation increases the risk of early onset type 2 diabetes. Using a case–control design, we
examined whether the reported variants [rs12255372 (T/G) and rs7903146 (T/C)] are associated
with type 2 diabetes in SEARCH for Diabetes in Youth study participants.
Methods—Variants were genotyped in 694 non-Hispanic white (NHW) youth (86 cases, mean
age 15.5 years, mean BMI 34.8; and 608 controls, mean age 14.4 years, mean BMI 22.3) and 545
African-American (AA) youth (154 cases, mean age 15.9, mean BMI 37; and 391 controls, mean
age 14.8, mean BMI 23.8). Logistic regression adjusted for age, sex, BMI and West African
ancestry.
Results—The association of the risk T allele with case/control status was different in AA and
NHW youth (p=0.025). Among AA youth, each copy of the T allele (rs7903146) was associated
with a 1.97-fold (1.37, 2.82) increased odds for type 2 diabetes (p<0.0001), after adjustment for
age, sex, BMI and African ancestry. No significant association was detected in NHW youth
(adjusted OR, 1.14; 0.73, 1.79).
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Conclusion/interpretation—TCF7L2 variation is associated with an increased risk of early-
onset type 2 diabetes among AA youth, and the association appears to be stronger in AA than
NHW youth. This suggests potential different contributions of genetic and environmental factors
to early-onset type 2 diabetes by race.
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Introduction
Recent studies have demonstrated that common variants of the transcription factor 7-like 2
(TCF7L2) gene are associated with adult-onset type 2 diabetes. Meta-analyses indicate that
the association between TCF7L2 and adult-onset type 2 diabetes is highly reproducible [1,
2] and suggest an additive effect [1].
Type 2 diabetes is now being reported in adolescents and even children. The SEARCH study
identified youth with type 2 diabetes in all major racial/ethnic groups in the USA [3].
However, no studies have directly tested the association between TCF7L2 and early-onset
type 2 diabetes, where the size of effect may be larger. We hypothesised that there would be
a significant association between TCF7L2 risk-conferring variants (rs12255372 and
rs7903146) and type 2 diabetes prevalence in 10- to 22-year-old youth of non-Hispanic
white (NHW) and African-American (AA) origin, independent of age, sex, race/ethnicity
and current levels of adiposity.
Methods
Identification of cases and controls
Youth eligible for inclusion as cases were all youth age 10–22 years with a clinical diagnosis
of type 2 diabetes, who participated in the SEARCH research visit, provided a DNA sample,
and self-reported their race/ethnicity as NHW or AA. SEARCH is an on-going multicentre
study that conducts population-based ascertainment of diabetes in youth [3]. Cases are
identified in geographically defined populations in Ohio, Washington, South Carolina and
Colorado and among youth enrolled in managed healthcare plans in Hawaii and California
[3]. Control participants who were not diabetic were recruited from population-based studies
in Ohio, Colorado and South Carolina [4] and group-matched to cases on race/ethnicity.
Control participants reported no known family history of diabetes and were confirmed to be
diabetes-free by fasting plasma glucose testing.
The study was approved by the local institutional review boards, and consent was given by
all participants for DNA testing. Weight and height were measured and BMI was calculated.
Among controls, fasting insulin and glucose levels were used to estimate insulin secretion
and resistance using the homeostasis model assessment (HOMA-B and HOMA-IR)
equations [5]. Among cases, fasting blood samples were obtained and analysed for glutamic
acid decarboxylase-65 and insulinoma-associated-2 autoantibodies using a standardised
assay protocol developed by the standardisation group sponsored by the National Institute of
Diabetes and Digestive and Kidney Diseases. Testing for the most common subtypes of
maturity onset diabetes of the young (HNF1A, GCK and HNF4Aα) was conducted in A.
Hattersley’s laboratory in Exeter, UK. Youth with diabetes were included if they were
negative for both autoantibodies and negative for mutations in these genes, resulting in the
exclusion of 35 participants with clinical type 2 diabetes and positive autoantibodies and 14
cases with MODY-related mutations.
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The single nucleotide polymorphism (SNP) variants rs7903146 and rs12255372 were
genotyped using DNA extracted from peripheral blood leucocytes and quantified with Pico-
Green analysis (Molecular Probes, Eugene, OR, USA). Genotyping was performed by
allele-specific primer extension of singleplex amplified products, with detection by matrix-
assisted laser desorption–ionisation time-of-flight mass spectroscopy on a Sequenom
platform [6]. The allele frequencies for both SNPs in each of the two racial/ethnic groups
were in Hardy–Weinberg equilibrium (p>0.05). In addition, 54 ancestry informative markers
were genotyped to evaluate the proportion of African and European ancestry in each sample,
using STRUCTURE, a computer software package available at http://www.stats.ox.ac.uk/
~pritch/home.html [7], trained on the HapMap CEU (European) and YRI (West African)
populations. Ancestry informative markers were chosen to maximally differentiate the
proportion of European and African ancestry in the AA admixed population. No effort was
made to include markers that distinguish between the Asian and European or Asian and
African populations. Given the historical genealogy of AA, we do not believe that
undetected Asian ancestry plays a significant role in the great majority of our participants.
Statistical analyses
Logistic regression was used to calculate ORs and 95% CIs, for the association between the
risk T-allele and case/control status, stratified according to race/ethnicity, using an additive
model. We adjusted for age, sex, BMI and proportion of African ancestry. Heterogeneity of
results between NHW and AA youth was assessed by a χ2 statistic. Among controls,
analysis of variance was used to explore the association of the risk T-allele with quantitative
traits (BMI, glucose, insulin, HOMA-IR and HOMA-B levels).
Results
A total of 240 youth with type 2 diabetes and 999 control participants were included.
Characteristics of the youth are shown in Table 1. The mean age was 15.7 years for those
with diabetes and 14.5 years for control youth. As expected, youth with type 2 diabetes had
higher BMI levels than the control youth. Mean estimated African ancestry was not
statistically different among the case and control groups by self-reported race/ethnic group.
Table 2 shows that among AA youth, each copy of the T allele (rs7903146) was associated
with a 1.97-fold (95% CI 1.37–2.82) increased adjusted odds for type 2 diabetes (p=0.0002).
No significant association with this allele was detected in NHW youth (adjusted OR, 1.09;
95% CI 0.70–1.70; test for heterogeneity p=0.025). For rs12255372, the results were less
conclusive and non-significant associations were noted for both racial/ethnic groups. Similar
findings were noted for the association of TCF7L2 genotypes and case/control status.
Among AA youth, the adjusted OR for type 2 diabetes was 4.27 (95% CI 1.95–9.35) for
homozygotes and 1.87 (95% CI 1.08–3.23) for heterozygotes at rs7903146, whereas no
significant associations were observed for NHW youth (test for heterogeneity p=0.018). No
significant associations were noted for the rs12255372 for either racial/ethnic group. Among
controls, only glucose levels were higher for the T allele carriers at rs7903146 (p=0.02) and
rs12255372 (p=0.004), although there was also a non-significant tendency for HOMA-B
levels to be lower among carriers (p=0.09). Results are presented in the Electronic
supplementary material ESM Table 1.
Discussion
This is the first report on TCF7L2 variation in a sample of well-characterised youth with
type 2 diabetes and healthy controls in two racial/ethnic groups. We found a strong
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association among AA youth, with an effect size greater than previously seen in AA adults
[2]. No significant association was observed in NHW youth.
These data are consistent with a previous study in Finland among 11 young adults with
incident type 2 diabetes (OR 10.9) suggesting that an association with TCF7L2 might have a
more pronounced effect in participants with an earlier age at onset [8]. A study in Colorado
also identified that the allele and genotype frequencies of the two SNPs are associated (OR
up to 4.0) with antibody-negative, but not antibody-positive diabetes with onset before age
25 years [9]. The non-significant findings among NHW youth in our study may be the result
of the relatively small sample of cases (n=86). Several meta-analyses of data from multiple
studies in adults estimated an allelic risk around 40% [1, 2], which is not inconsistent with
the effect seen in NHW youth in our study (adjusted OR 1.09, 95% CI 0.70–1.70).
However, the effect of TCF7L2 on risk of adult onset type 2 diabetes was reported to be
similar in NHW and AA populations [2]. Estimates of allele frequencies for the T risk allele
among our controls are consistent in both racial/ethnic groups and with other published
reports in adults [1], suggesting that our controls were reasonably representative of the
NHW and AA in the USA. By virtue of their earlier age of onset of type 2 diabetes, youths
may have higher frequencies of risk alleles than those seen in adult-onset cases. Our data
suggest a greater contribution of TCF7L2 variation to early-onset type 2 diabetes among
youths of AA origin. Nevertheless, our 95% CI (1.37–2.82) spans the published OR (~1.4),
so we cannot state with certainty that the effect is stronger in younger AA people. In
contrast, different genes and environmental factors may be more important contributors to
early-onset type 2 diabetes among NHW youth. TCF7L2 variation leads to type 2 diabetes
by an impairment in insulin secretion, rather than insulin resistance [10]. Our findings that
the association of TCF7L2 and type 2 diabetes in youth is independent of BMI, and the
relationship between TCF7L2 variation and quantitative traits among controls are consistent
with previous reports. A recent study has shown that the rs7903146 polymorphism modifies
an enhancer element [11]. The stronger effects seen for rs7903146 when compared with
rs12255372 in AA youth supports the hypothesis that rs7903146 is a strong candidate for the
functional variant. Our study was limited by the small number of NHW youth with type 2
diabetes, because of the relative rarity of the condition. Additionally, our conclusions are
limited to NHW and AA youth. Although the SEARCH study includes other racial/ethnic
groups (Hispanics, Asian/Pacific Islanders and Native Americans), the samples sizes were
small and no appropriate control groups were available. We focused on TCF7L2 because it
is the strongest type 2 diabetes association reported to date and the only one for which we
had adequate statistical power. However, to date, our study is the largest case–control study
of youth with type 2 diabetes that includes NHW and AA youth from a population-based
study, with a well characterised phenotype.
In conclusion, TCF7L2 variation is strongly associated with an increased risk of early-onset
type 2 diabetes among AA youth in the USA. This association is independent of obesity,
with the effect size being larger than previously seen in adults. The stronger association
between TCF7L2 variation and type 2 diabetes in AA youth than NHW youth suggests
potential different contributions of genetic and/or environmental factors to early-onset type 2
diabetes in various racial/ethnic groups and requires further study.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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